Der foreligger ikke tilstrækkelig dokumentation for at udelukke teratogen effekt, hvis rekombinant h- FSHanvendes under graviditet.
In case of exposure during pregnancy, clinical data are not sufficient to exclude a teratogenic effect of recombinant FSH.